Skip Navigation
Contact Us
Client Login
Search
Our People
Our Capabilities
Our Firm
About Us
Alumni Network
Careers
Insights
News
Events
Publications
Blogs & Podcasts
Offices & Locations
Our Diverse Culture
People
6 Search Results for:
Z
Jessica Zaiger
Capital Markets & Commercial Lending Co-Chair
Kansas City
816.572.4419
jzaiger@polsinelli.com
Michael E. Zawalski
Associate
St. Louis
314.622.6145
MZawalski@Polsinelli.com
Janet E. Zeigler
Shareholder
Chicago
312.873.3679
jzeigler@polsinelli.com
Tiffany Zeigler
Chief Marketing & Business Development Officer
Atlanta
404.253.6296
tzeigler@polsinelli.com
Jeffrey J. Zissa
Shareholder
Dallas
214.661.5562
jzissa@polsinelli.com
Shelby D. Zumwalt
Associate
Dallas
214.754.5778
szumwalt@polsinelli.com
Type a name or keyword
Select a title
Select a capability
Select an office
Select a bar admission
Select a school
Search
Firm Highlights
Slide 1 of 6
Event
Polsinelli Pulse Series: Shelf Space – Strategies for Dominating the CPG Marketplace
Join Polsinelli as we speak with investors in, and founders of, your favorite CPG brands, to learn what they’ve done right, what they’ve done wrong, and what they’re still trying to figure out.
Read more
Blog
Where Identity Meets Precedent: The EEOC Addresses Bathroom and Locker Room Access Under Title VII
Read more
News
Polsinelli Secures Dismissal of Data Breach Class Action for Delta Health
Polsinelli recently secured a significant win for firm client Delta County Memorial Hospital District (Delta Health), obtaining dismissal of a putative data breach class action in the District Court for Delta County, Colorado.
Read more
News
Polsinelli Advises Americana Partners on Acquisition of NRT Consulting
Polsinelli recently represented Americana Partners (Americana), a Houston-based wealth management firm, in its acquisition of NRT Consulting, a bespoke and full-service financial consulting and accounting firm.
Read more
Publication
Not Joking Around: FDA Offers Additional Clarification on Compounded GLP-1 Policy in April Fool’s Day Announcement
FDA's April 1, 2026, update to its compounding policy page follows more than 18 months of regulatory activity surrounding the compounding of GLP-1 medications.
Read more
Publication
The Politics of AI Regulation: Federal Government v. the States
On December 11, 2025, President Trump signed Executive Order 14365, “Ensuring a National Policy Framework for Artificial Intelligence.”
Read more